Atai Beckley N.V.
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Emerging growth company
State of Incorporation Netherlands
Country Netherlands
Business Address PROF. J.H. BAVINCKLAAN 7, AMSTELVEEN, , 1183
Mailing Address PROF. J.H. BAVINCKLAAN 7, AMSTELVEEN, , 1183
Phone 49 89 2153 9035
Fiscal Year End 1231
EIN 000000000
Financial Overview
FY2024 FY
$314K
Revenue
-$40.22M
Net Income
$49.16M
Total Liabilities
$45.03M
Cash & Equivalents
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | December 5, 2025 | View on SEC |
| 4 Insider stock transaction report | November 26, 2025 | View on SEC |
| 10-Q Quarterly financial report | November 12, 2025 | View on SEC |
| 8-K Current report of material events | November 12, 2025 | View on SEC |
| 4 Insider stock transaction report | November 6, 2025 | View on SEC |
| 4 Insider stock transaction report | November 6, 2025 | View on SEC |
| 3 Initial insider ownership report | November 6, 2025 | View on SEC |
| 4 Insider stock transaction report | November 6, 2025 | View on SEC |
| 3 Initial insider ownership report | November 6, 2025 | View on SEC |
| 8-K Current report of material events | November 5, 2025 | View on SEC |
Material Events
8-K Other December 5, 2025
Low Impact
- Atai Beckley N.V. filed a prospectus supplement with the SEC to officially register common shares.
- These shares were previously issued as part of the acquisition of Beckley Psytech Limited.
Related Companies
Companies in the same industry (SIC: 2834)
Werewolf Therapeutics, Inc.
HOWL Pharmaceutical Preparations
Zenas BioPharma, Inc.
ZBIO Pharmaceutical Preparations
Centessa Pharmaceuticals plc
CNTA Pharmaceutical Preparations
Karyopharm Therapeutics Inc.
KPTI Pharmaceutical Preparations
VERTEX PHARMACEUTICALS INC / MA
VRTX Pharmaceutical Preparations
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.